1. Clinical relevance of bacterial resistance in lower respiratory tract infection in primary care: secondary analysis of a multicentre European trial.
- Author
-
Teepe J, Broekhuizen BD, Goossens H, Hordijk PM, Loens K, Lammens C, Ieven M, Little P, Butler CC, Coenen S, Godycki-Cwirko M, Henriques-Normark B, and Verheij TJ
- Subjects
- Acute Disease, Adult, Aged, Amoxicillin pharmacology, Anti-Bacterial Agents pharmacology, Cough drug therapy, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Placebos, Respiratory Tract Infections drug therapy, Respiratory Tract Infections physiopathology, Treatment Outcome, Amoxicillin therapeutic use, Anti-Bacterial Agents therapeutic use, Cough microbiology, Drug Resistance, Bacterial drug effects, Primary Health Care, Respiratory Tract Infections microbiology
- Abstract
Background: The impact of antimicrobial resistance on clinical outcomes in patients with lower respiratory tract infection in primary care is largely unknown., Aim: To determine the illness course of infections with resistant bacteria in adults presenting to primary care with acute cough., Design and Setting: Secondary analysis of a multicentre European trial in primary care., Method: A total of 2061 adults with acute cough (lasting ≤28 days) were recruited from primary care and randomised to amoxicillin or placebo. To reflect the natural course of disease, only patients in the placebo group ( n = 1021) were eligible. Nasopharyngeal flocked swabs and/or sputa (when available) were analysed at baseline and Streptococcus pneumoniae and Haemophilus influenzae isolates underwent susceptibility testing. Patients recorded their symptoms in a diary every day for 4 weeks. Patients with and without resistant bacterial infection were compared with regards to symptom severity, duration of symptoms, worsening of illness, and duration of interference with normal activities or work., Results: Of the 834 patients with diary records, 104 showed S. pneumoniae and/or H. influenzae infection. Of this number, 54 (52%) were resistant to antibiotics, while seven (7%) were resistant to penicillin. For the duration of symptoms rated 'moderately bad or worse' (hazard ratio 1.27, 95% confidence interval [CI] = 0.67 to 2.44), mean symptom severity (difference -0.48, 95% CI = -1.17 to 0.21), and worsening of illness (odds ratio 0.31, 95% CI = 0.07 to 1.41), there was no statistically significant difference between the antibiotic-resistant and antibiotic-sensitive groups., Conclusion: The illness course of antibiotic-resistant lower respiratory tract infection does not differ from that caused by antibiotic-sensitive bacteria., (© British Journal of General Practice 2018.)
- Published
- 2018
- Full Text
- View/download PDF